Access cutting-edge i cannot determine the primary medical condition from the provided information. the study title mentions mesenchymal stromal cells but doesn't specify what condition is being treated, and the conditions listed appear to be interventions rather than medical conditions. the brief summary field is empty/incomplete. treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Chicago location
Access i cannot determine the primary medical condition from the provided information. the study title mentions mesenchymal stromal cells but doesn't specify what condition is being treated, and the conditions listed appear to be interventions rather than medical conditions. the brief summary field is empty/incomplete. specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related i cannot determine the primary medical condition from the provided information. the study title mentions mesenchymal stromal cells but doesn't specify what condition is being treated, and the conditions listed appear to be interventions rather than medical conditions. the brief summary field is empty/incomplete. treatment provided free
Check if you qualify for this i cannot determine the primary medical condition from the provided information. the study title mentions mesenchymal stromal cells but doesn't specify what condition is being treated, and the conditions listed appear to be interventions rather than medical conditions. the brief summary field is empty/incomplete. clinical trial in Chicago, IL
No-Cost Study Care
Local to Chicago
Convenient for IL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The proposed Conventional Cohort Expansion Study involves the use of Mesenchymal Stromal Cells (MSCs) are derived from the bone marrow. We previously studied the safety of subconjunctival injection of allogeneic bone marrow-derived MSCs in patients with nonhealing epitheliopathy (IRB Protocol 2020-0334). In the present study, we want to study the efficacy of this treatment on chronic epitheliopathies.
Sponsor: University of Illinois at Chicago
Yes, this clinical trial (NCT05705024) has an active research site in Chicago, IL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for i cannot determine the primary medical condition from the provided information. the study title mentions mesenchymal stromal cells but doesn't specify what condition is being treated, and the conditions listed appear to be interventions rather than medical conditions. the brief summary field is empty/incomplete. treatment options in Chicago, IL, this clinical trial (NCT05705024) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced i cannot determine the primary medical condition from the provided information. the study title mentions mesenchymal stromal cells but doesn't specify what condition is being treated, and the conditions listed appear to be interventions rather than medical conditions. the brief summary field is empty/incomplete. specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all i cannot determine the primary medical condition from the provided information. the study title mentions mesenchymal stromal cells but doesn't specify what condition is being treated, and the conditions listed appear to be interventions rather than medical conditions. the brief summary field is empty/incomplete. clinical trials near you to find additional studies recruiting in your area.
See all multiple myeloma clinical trials recruiting in Chicago — not just this study.
Browse Multiple Myeloma Trials in Chicago →